top of page
FINANCIAL NEWS
Sun Pharma Eyes Day-1 Launch of Semaglutide in India; Monitors Specialty Portfolio Amid Global Price Gaps
Sun Pharma plans Day-1 launch of Semaglutide in India post patent expiry, sees high opportunity in the market, and monitors global developments impacting its specialty drug portfolio
1:01 pm
1 August 2025
Reliance Infrastructure Refutes ₹10,000 Cr Diversion Claim, Clarifies ₹6,500 Cr Exposure already Disclosed
Reliance Infrastructure responds to media report alleging ₹10,000 crore fund diversion; clarifies actual exposure at ₹6,500 crore, fully disclosed and under recovery through mediation.
12:35 pm
1 August 2025
bottom of page